Gossamer Bio Inc (GOSS)

Jun 16, 2025

Gossamer Bio Announces Completion of Enrollment in Registrationa - GuruFocus

Jun 16, 2025

Jun 16, 2025

Gossamer Bio (GOSS) Wraps Up Enrollment for Phase 3 PAH Study | GOSS Stock News - GuruFocus

Jun 16, 2025

Jun 16, 2025

Gossamer Bio Announces Completion Of Enrollment In Registrational Phase 3 PROSERA Study For The Treatment Of PAH - marketscreener.com

Jun 16, 2025

Jun 16, 2025

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH - New Castle News

Jun 16, 2025

Jun 16, 2025

Gossamer Bio's Breakthrough PAH Drug Hits Major Milestone: 390 Patients Enrolled in Phase 3 Trial - Stock Titan

Jun 16, 2025

Jun 11, 2025

Squarepoint Ops LLC Has $65,000 Stake in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Jun 11, 2025

Jun 11, 2025

Brokers Offer Predictions for Gossamer Bio FY2026 Earnings - Defense World

Jun 11, 2025

Jun 08, 2025

Two Sigma Investments LP Raises Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Jun 08, 2025

Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus

Jun 06, 2025

Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | GOSS Stock News - GuruFocus

Jun 06, 2025

Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule - marketscreener.com

Jun 06, 2025

Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 06, 2025

May 26, 2025

HC Wainwright Increases Earnings Estimates for Gossamer Bio - Defense World

May 26, 2025

May 22, 2025

Cantor Fitzgerald Forecasts Gossamer Bio FY2025 Earnings - Defense World

May 22, 2025

May 20, 2025

Analyze Gossamer Bio Inc (NASDAQ: GOSS) Before Investing. - Stocksregister

May 20, 2025

May 19, 2025

Price T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

May 19, 2025

May 18, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025

May 18, 2025

Wedbush Reiterates “Outperform” Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

May 18, 2025

May 18, 2025

The Goldman Sachs Group Raises Gossamer Bio (NASDAQ:GOSS) Price Target to $8.00 - Defense World

May 18, 2025

May 17, 2025

GOSS Stock Update: Analyst Reiterates Outperform Rating | GOSS S - GuruFocus

May 17, 2025

May 16, 2025

Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 16, 2025

May 16, 2025

Gossamer Bio (GOSS): Goldman Sachs Raises Price Target to $8.00 - GuruFocus

May 16, 2025

May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock - Investing.com

May 16, 2025

May 16, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Gossamer Bio: Q1 Earnings Snapshot - CT Insider

May 16, 2025

May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ... - Yahoo Finance

May 16, 2025

May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strate - GuruFocus

May 16, 2025

May 15, 2025

Transcript : Gossamer Bio, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025

May 15, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts - Investing.com Australia

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025

May 15, 2025

Gossamer Bio earnings beat by $0.03, revenue topped estimates - Investing.com

May 15, 2025

May 15, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings: EPS Loss of $0.16 Beats Estimate, Revenue Surges to $9.9 Million - GuruFocus

May 15, 2025

May 15, 2025

GOSSAMER BIO Earnings Results: $GOSS Reports Quarterly Earnings - Nasdaq

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key St - GuruFocus

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key Studies | GOSS Stock News - GuruFocus

May 15, 2025

May 15, 2025

Gossamer Bio, Inc. SEC 10-Q Report - TradingView

May 15, 2025

May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study - Eagle-Tribune

May 15, 2025

May 15, 2025

Gossamer Bio Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025

May 14, 2025

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings - GuruFocus

May 14, 2025

May 12, 2025

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025 - Eagle-Tribune

May 12, 2025

May 07, 2025

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference - The Joplin Globe

May 07, 2025

May 07, 2025

Market Highlights: Gossamer Bio Inc (GOSS) Ends on a Low Note at 1.09 - DWinneX

May 07, 2025

May 05, 2025

Gossamer Bio Inc: Is GOSS Stock Worth Buying? - Stocksregister

May 05, 2025

May 04, 2025

Gossamer Bio (GOSS) Expected to Announce Earnings on Tuesday - Defense World

May 04, 2025

May 02, 2025

Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha

May 02, 2025